Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome - Wikidata - awgldk - TriplyDB

Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome

Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome

http://www.wikidata.org/entity/Q33441886

about

Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome

http://www.wikidata.org/entity/Q33441886

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Successful treatment by tocili ...... severe case of TAFRO syndrome

@ast

Successful treatment by tocili ...... severe case of TAFRO syndrome

@en

type

label

Successful treatment by tocili ...... severe case of TAFRO syndrome

@ast

Successful treatment by tocili ...... severe case of TAFRO syndrome

@en

prefLabel

Successful treatment by tocili ...... severe case of TAFRO syndrome

@ast

Successful treatment by tocili ...... severe case of TAFRO syndrome

@en

P1433

Q33441886-18D40D41-6C0B-4097-9EC1-93DD89B76F85

P1476

Q33441886-2CF587DE-8132-4601-BBBD-2BD030192757

P2093

Q33441886-12F0CFFC-1AE7-474E-BC0E-59F26DABAF43

Q33441886-359FD710-B4AD-4FBB-93D4-C8FA89208AC8

Q33441886-6FB519F3-1C61-49ED-AD57-E72FD054CCEC

Q33441886-9E277E70-29FB-43B3-BD24-8DD9D4998856

P2860

Q33441886-20AD252B-9927-4002-97AE-04DF01346976

Q33441886-21839C9E-6ACC-4348-A14F-6E3133C09C1E

Q33441886-32847B9F-A1B7-4858-B479-838F74691078

Q33441886-417812E8-0E39-49A8-8C12-CEC2E64401C2

Q33441886-44C54C64-05AD-4300-A7FA-AE8A8CC9BFA8

Q33441886-48FD2E08-2E73-4C4C-A152-139DA2AE520B

Q33441886-630D32CB-4669-4DEA-8DCC-B53C82EA1F8B

Q33441886-6E3B9526-4DBB-4D8A-9F54-1124812F2850

Q33441886-864E0201-B5EE-453C-BC22-5F38FAC0FF30

Q33441886-974DF23B-1094-4BEB-93A5-4C153A2BAC4E

P2888

Q33441886-ACF9CD0D-8933-4304-8641-7D7C92C6C2C4

P304

Q33441886-E82993B6-9126-4D82-B171-DC40F2C5E26B

P31

Q33441886-DC160E75-9A19-4112-9193-B57D376CE03D

Q33441886-c94200a3-8da8-46dc-8a6c-a1a6c6c5b1c7

P356

Q33441886-55047371-94D1-488D-881C-6F1DF398E0C0

P433

Q33441886-FFD43F75-6250-4F12-8BAD-DEF0C6DA443E

P478

Q33441886-CF3B3FCA-E6C5-40A2-99DA-F4D28DE5440D

P50

Q33441886-9F5412AF-2DAC-43A6-8C8A-08A4FCCF9FA4

P577

Q33441886-21F6D394-D648-41FB-B7C4-CE9E6CE66085

P6179

Q33441886-0C76EA64-29C6-4197-BB04-D5898CD7A7F4

P698

Q33441886-7D2ED390-05DB-4F38-9D9C-7D67A4B507F2

P932

Q33441886-27953995-126F-4E14-96F0-136D39680599

P356

S13730-017-0253-6

P1433

CEN case reports

P1476

Successful treatment by tocili ...... severe case of TAFRO syndrome

@en

P2093

Ryoichi Ando

http://www.w3.org/2001/XMLSchema#string

Seishi Watanabe

http://www.w3.org/2001/XMLSchema#string

Shunsuke Iwamoto

http://www.w3.org/2001/XMLSchema#string

Suguru Hirasawa

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.

Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.

Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.

The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.

Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.

Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.

P2888

s13730-017-0253-6

P304

105-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13730-017-0253-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084037280

http://www.w3.org/2001/XMLSchema#string

P698

28509137

http://www.w3.org/2001/XMLSchema#string

P932

5438817

http://www.w3.org/2001/XMLSchema#string